Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in KYTX — Kyverna Therapeutics, Inc.

CIK 1214717 BOSTON, MA
Back to KYTX Full portfolio

Position in KYTX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$9,350,421
+$5,692,804 QoQ
Shares Held
1,049,430
+147.6% QoQ
Ownership
1.70%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 120 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KYTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. KYTX ranks #193 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in KYTX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,350,421 1,049,430
2026-03-31 $3,657,617 423,826
2025-12-31 $2,504,178 266,402
2025-09-30 $1,669,974 278,329
2025-06-30 $882,934 287,601
2025-03-31 $1,088,469 563,974
2024-12-31 $2,018,410 539,682
2024-09-30 $2,167,795 443,312
2024-06-30 $2,794,484 372,598
2024-03-31 $4,278,342 172,236